EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C27H41N3O5 |
| Net Charge | 0 |
| Average Mass | 487.641 |
| Monoisotopic Mass | 487.30462 |
| SMILES | CCCC[C@H](C)[C@@H]1CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)O1 |
| InChI | InChI=1S/C27H41N3O5/c1-6-7-11-18(4)23-16-24(31)29-21(15-20-12-9-8-10-13-20)26(33)28-19(5)25(32)30-22(14-17(2)3)27(34)35-23/h8-10,12-13,17-19,21-23H,6-7,11,14-16H2,1-5H3,(H,28,33)(H,29,31)(H,30,32)/t18-,19-,21-,22+,23-/m0/s1 |
| InChIKey | ZKSLFHXTWGEITF-JIORRVSTSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Beauveria sp. (ncbitaxon:1891652) | cell suspension culture (BTO:0000221) | PubMed (10092189) | Strain: FO-6979 |
| Cordyceps militaris (ncbitaxon:73501) | - | PubMed (31926180) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | fungal metabolite Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds. EC 2.3.1.26 (sterol O-acyltransferase) inhibitor An EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the action of acyl-CoA:cholesterol acyltransferase (EC 2.3.1.26). |
| Applications: | geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. antiatherogenic agent A cardiovascular drug that prevents atherogenesis, the accumulation of lipid-containing plaques on the innermost layers of the arteries. Compare with antiatherosclerotic agent. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| beauveriolide I (CHEBI:180490) has role antiatherogenic agent (CHEBI:50855) |
| beauveriolide I (CHEBI:180490) has role antiatherosclerotic agent (CHEBI:145947) |
| beauveriolide I (CHEBI:180490) has role EC 2.3.1.26 (sterol O-acyltransferase) inhibitor (CHEBI:64696) |
| beauveriolide I (CHEBI:180490) has role fungal metabolite (CHEBI:76946) |
| beauveriolide I (CHEBI:180490) has role geroprotector (CHEBI:176497) |
| beauveriolide I (CHEBI:180490) is a cyclodepsipeptide (CHEBI:35213) |
| beauveriolide I (CHEBI:180490) is a macrocycle (CHEBI:51026) |
| IUPAC Name |
|---|
| (3R,6S,9S,13S)-9-benzyl-13-[(2S)-hexan-2-yl]-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotridecane-2,5,8,11-tetrone |
| Manual Xrefs | Databases |
|---|---|
| 8088999 | ChemSpider |
| US2003143716 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:154491-55-1 | ChEBI |
| Citations |
|---|